ProfileGDS4718 / 240778_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 31% 30% 28% 34% 27% 25% 28% 33% 25% 34% 24% 25% 20% 18% 30% 29% 27% 22% 21% 30% 35% 27% 23% 26% 32% 24% 22% 26% 27% 19% 19% 22% 25% 29% 21% 15% 24% 28% 29% 28% 26% 21% 23% 21% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6046431
GSM549102patient 115, normal, homogenized [OPG study]4.5487130
GSM549104patient 119, normal, homogenized [OPG study]4.424728
GSM549108patient 138, normal, homogenized [OPG study]4.7615934
GSM549119patient 077, normal, homogenized [OPG study]4.4334727
GSM549133patient 032, cancer, homogenized [OPG study]4.2949125
GSM549139patient 042, cancer, homogenized [OPG study]4.4418428
GSM549099patient 107, normal, homogenized [OPG study]4.7095733
GSM549109patient 139, normal, homogenized [OPG study]4.3685725
GSM549110patient 046, normal, homogenized [OPG study]4.7269534
GSM549114patient 063, normal, homogenized [OPG study]4.2524
GSM549122patient 082, normal, homogenized [OPG study]4.352825
GSM549134patient 033, cancer, homogenized [OPG study]4.1236820
GSM549136patient 036, cancer, homogenized [OPG study]4.006918
GSM549140patient 044, cancer, homogenized [OPG study]4.4822530
GSM549111patient 047, normal, homogenized [OPG study]4.4717429
GSM549113patient 057, normal, homogenized [OPG study]4.3740127
GSM549132patient 031, cancer, homogenized [OPG study]4.2245222
GSM549137patient 038, cancer, homogenized [OPG study]4.1795121
GSM549142patient 047, cancer, homogenized [OPG study]4.63930
GSM549100patient 110, normal, homogenized [OPG study]4.7652335
GSM549107patient 135, normal, homogenized [OPG study]4.3881127
GSM549115patient 068, normal, homogenized [OPG study]4.2248423
GSM549116patient 072, normal, homogenized [OPG study]4.3409826
GSM549120patient 078, normal, homogenized [OPG study]4.6392932
GSM549131patient 030, cancer, homogenized [OPG study]4.2291224
GSM549118patient 074, normal, homogenized [OPG study]4.220722
GSM549129patient 027, cancer, homogenized [OPG study]4.4083226
GSM549123patient 088, normal, homogenized [OPG study]4.4204627
GSM549124patient 006, cancer, homogenized [OPG study]4.1542219
GSM549126patient 015, cancer, homogenized [OPG study]4.0810419
GSM549128patient 025, cancer, homogenized [OPG study]4.2115922
GSM549103patient 117, normal, homogenized [OPG study]4.3990825
GSM549117patient 073, normal, homogenized [OPG study]4.4714829
GSM549138patient 041, cancer, homogenized [OPG study]4.1460721
GSM549141patient 045, cancer, homogenized [OPG study]3.8913115
GSM549130patient 028, cancer, homogenized [OPG study]4.311424
GSM549101patient 111, normal, homogenized [OPG study]4.4725528
GSM549105patient 128, normal, homogenized [OPG study]4.5162629
GSM549106patient 134, normal, homogenized [OPG study]4.3894928
GSM549112patient 048, normal, homogenized [OPG study]4.370626
GSM549125patient 011, cancer, homogenized [OPG study]4.1782421
GSM549127patient 024, cancer, homogenized [OPG study]4.2455123
GSM549135patient 035, cancer, homogenized [OPG study]4.1439521